![N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]prop-2-enamide](https://static.cymitquimica.com/cas-image/299203-n-4-3-chloro-4-3-fluorophenyl-methoxy-anilino-quinazolin-6-yl-prop-2-enamide.png)
CAS: 897383-62-9 - N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]prop-2-enamide
Formula:C24H18ClFN4O2
InChI:InChI=1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30)
- Synonyms:
- Ast-1306
- Allitinib(AST-1306)
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Allitinib REF: TM-T14336CAS: 897383-62-9 | 99.10% - 99.28% | 51.00 €~1,792.00 € | Tue 10 Dec 24 |
 | Allitinib REF: IN-DA00GU10CAS: 897383-62-9 | 98% | To inquire | Tue 10 Dec 24 |
 | AST-1306 REF: 3D-XKB38362CAS: 897383-62-9 | Min. 95% | To inquire | Tue 21 Jan 25 |
Allitinib
CAS:897383-62-9
Allitinib (AST-1306) (AST-1306) has anti-cancer activity,and it is an irreversible EGFR and ErbB2 inhibitor with …
Formula:
C24H18ClFN4O2
Purity:
99.10% - 99.28%
Color and Shape:
Solid
Molecular weight:
448.88
Ref: TM-T14336
| 1mg | 51.00 € | ||
| 5mg | 107.00 € | ||
| 10mg | 170.00 € | ||
| 25mg | 318.00 € | ||
| 50mg | 476.00 € | ||
| 100mg | 675.00 € | ||
| 1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Allitinib
CAS:897383-62-9
Formula:
C24H18ClFN4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
448.8767
Ref: IN-DA00GU10
| 1mg | 150.00 € | ||
| 5mg | 272.00 € | ||
| 10mg | 645.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
AST-1306
CAS:897383-62-9
AST-1306 is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) and …
Formula:
C24H18ClFN4O2
Purity:
Min. 95%
Molecular weight:
448.88 g/mol
Ref: 3D-XKB38362
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
